Valuation: Novartis AG

Market Cap 293B 258B 239B 220B 413B 28,363B 420B 2,862B 1,116B 13,834B 1,100B 1,076B 47,995B P/E 2026 *
21.1x
P/E 2027 * 18.3x
Enterprise Value 324B 285B 264B 243B 456B 31,329B 464B 3,161B 1,233B 15,281B 1,215B 1,188B 53,015B EV / Sales 2026 *
5.63x
EV / Sales 2027 * 5.25x
Free-Float
91.66%
Yield 2026 *
2.84%
Yield 2027 * 2.99%
1 day+1.05%
1 week+4.64%
Current month+0.85%
1 month+6.14%
3 months+10.45%
6 months+10.91%
Current year+16.48%
1 week 121.68
Extreme 121.68
127.66
1 month 121.06
Extreme 121.06
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.56
Extreme 91.56
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.85%+4.64%+38.53%+39.87% 293B
+1.97%+1.38%+48.37%+158.06% 1,037B
+1.42%+3.72%+53.32%+51.55% 615B
+1.43%+0.95%+34.77%+79.35% 448B
+5.14%+5.84%+37.54%+27.28% 326B
-0.11%+0.97%+22.57%+17.81% 264B
+0.25%-3.10%-24.44%-42.25% 216B
+1.49%-0.02%+20.14%+57.80% 198B
+0.40%-3.99%+15.23%+68.50% 162B
+0.77%-0.52%-1.38%-33.32% 141B
Average +1.27%+1.01%+24.47%+42.47% 369.89B
Weighted average by Cap. +1.47%+1.42%+34.87%+71.67%

Financials

2026 *2027 *
Net sales 57.47B 50.54B 46.95B 43.18B 80.98B 5,565B 82.43B 561B 219B 2,714B 216B 211B 9,417B 60.94B 53.6B 49.79B 45.79B 85.88B 5,902B 87.42B 595B 232B 2,879B 229B 224B 9,987B
Net income 13.97B 12.29B 11.42B 10.5B 19.69B 1,353B 20.04B 137B 53.25B 660B 52.46B 51.32B 2,290B 15.64B 13.76B 12.78B 11.75B 22.04B 1,515B 22.44B 153B 59.6B 739B 58.72B 57.45B 2,563B
Net Debt 30.63B 26.94B 25.03B 23.02B 43.16B 2,966B 43.94B 299B 117B 1,447B 115B 112B 5,019B 27.22B 23.94B 22.24B 20.45B 38.36B 2,636B 39.04B 266B 104B 1,286B 102B 99.97B 4,460B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
23/07/26 CHF 127.66 +1.85% 2,482,939
22/07/26 CHF 125.34 -0.16% 2,648,334
21/07/26 CHF 125.54 +1.98% 3,462,607
20/07/26 CHF 123.10 -1.52% 1,700,014
17/07/26 CHF 125.00 +1.41% 2,979,184
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
154.09USD
Average target price
153.86USD
Spread / Average Target
-0.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock